Skip to main content
letter
. 2021 May 6;116(5):1003–1006. [Article in Portuguese] doi: 10.36660/abc.20200873

Table 1. Relative changes in Acute Coronary Syndrome diagnoses and in-hospital mortality before and during initial period of Covid-19 outbreak in the current analysis and in the international literature (North Italy4, Kaiser Permanente5, Italian Registry6).

Total ACSa STEMI NSTEMI In-hospital mortality
North Italyb 28% reduction 24% reduction 43% reduction Not available
Kaiser Permanentec 48% reduction 40% reduction 49% reduction Not available
Italian Registryd 48.4% reduction 26.5% reduction 65.1% reduction RRoverall= 3.6 (2.0–6.4)
RRSTEMI= 3.3 (1.7–6.6)
Brazilian Networke 36.5% reductione 28.9% reductione 39.5% reductione RRoverall= 0.85 (0.4-1.7)e
RRSTEMI= 1.2 (0.3-4.0)e

ACS: Acute Coronary Syndrome; STEMI: ST-Elevation Myocardial Infarction; NSTEMI: Non-ST-Elevation Myocardial infarction; RR: Risk Ratio.

a

In the reports from Kaiser Permanente and Italian Registry, only acute myocardial infarction was evaluated.

b

Retrospective analysis of consecutive patients who were admitted for acute coronary syndrome at 15 hospitals in northern Italy, comparing February and March to two control periods: a corresponding period in the previous year (2019) and an earlier period in the same year (2020)4. We reported the average from both analyses.

c

The comparison reported was based on a database of a health care delivery system from January through March 2020, compared to data from April 20205.

d

Data based on a nationwide survey regarding admissions for acute myocardial infarction at Italian coronary care units in a one-week period during the Covid-19 outbreak, and compared with the equivalent week in 20196.

e

Comparison between the average of the first three months of the Covid-19 pandemic (94 ACS per month; 21 STEMI per month; 53.3 NSTEMI per month) and the average of the previous 12 months (148.1 ACS per month; 29.5 STEMI per month; 88.1 NSTEMI per month). Overall, the mortality rate was 3.4% (61/1777) in the previous 12 months and 2.9% in the first three months of the pandemic (9/306). The mortality was 3.9% among STEMI patients (14/354) in the previous 12 months and 4.7% (3/63) in the first three months of the pandemic.